DM005: An anti-EGFR/c-MET bispecific antibody-drug conjugate for advanced solid tumors. Pan-tumor application of trastuzumab deruxtecan (T-DXd) monotherapy in HER2 3+ advanced solid tumors: A pilot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results